ECRI Institute, one of the leading patient safety and medical technology research organizations, places health technology cybersecurity at the top of its just-released 2019 Top 10 Health Technology Hazards.
Newcastle University wins NICE AdviSeME Prize
NICE Scientific Advice has announced that Newcastle University is the first winner of the NICE AdviSeME Prize for its prognostic skin cancer test.
The test, called AMBLor, aims to improve the detection and prognosis of patients diagnosed with melanoma.
The test will identify people who have the highest risk of their disease getting worse so that their condition can be monitored more closely.
It should also provide these patients with earlier access to potentially life-saving treatments.
In addition the test can identify those with low risk of their disease getting worse meaning they can be discharged earlier, avoiding unnecessary appointments and saving the NHS money.
Leeza Osipenko, head of NICE Scientific Advice, said: “Newcastle University will receive a free Light Scientific Advice Service from NICE, valued at £15,000. We will work with clinical and health economics experts to provide a comprehensive commentary on proposed evidence generation plans for AMBLor’s development and implementation to help demonstrate the value of this product to the NHS.”